000 01457 a2200421 4500
005 20250518005944.0
264 0 _c20190726
008 201907s 0 0 eng d
022 _a1809-452X
024 7 _a10.1590/1516-4446-2017-0021
_2doi
040 _aNLM
_beng
_cNLM
100 1 _ada Silva, Luciana R
245 0 0 _aCost-effectiveness analysis of the treatment of mild and moderate Alzheimer's disease in Brazil.
_h[electronic resource]
260 _bRevista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)
_c
300 _a218-224 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aAlzheimer Disease
_xdiagnosis
650 0 4 _aBrazil
650 0 4 _aCholinesterase Inhibitors
_xeconomics
650 0 4 _aCohort Studies
650 0 4 _aCost-Benefit Analysis
650 0 4 _aDonepezil
_xeconomics
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNational Health Programs
650 0 4 _aQuality-Adjusted Life Years
650 0 4 _aRivastigmine
_xeconomics
650 0 4 _aTreatment Outcome
700 1 _aVianna, Cid M M
700 1 _aMosegui, Gabriela B G
700 1 _aPeregrino, Antônio A F
700 1 _aMarinho, Valeska
700 1 _aLaks, Jerson
773 0 _tRevista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)
_gvol. 41
_gno. 3
_gp. 218-224
856 4 0 _uhttps://doi.org/10.1590/1516-4446-2017-0021
_zAvailable from publisher's website
999 _c29042760
_d29042760